Published in Drug Week, June 9th, 2006
This trend article about Emory University, Atlanta is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Yellow Fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.
According to a study from the United States, "The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most effective vaccines available, with a 65-year history of use in >400 million people globally. Despite this efficacy, there is presently no information about the immunological...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-06-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.